| Literature DB >> 27275278 |
Dragana Bislimovska1, Sunchica Petrovska1, Jordan Minov2.
Abstract
BACKGROUND: Results from many studies suggest that workplace exposure to organic dust may lead to adverse respiratory effects in exposed workers. AIM: In order to assess the respiratory effects of the workplace exposure to hardwood dust we performed a cross-sectional study of never-smoking male workers employed in parquet manufacture and never-smoking male office workers as a control.Entities:
Keywords: questionnaire; respiratory symptoms; spirometry; wood dust; workplace exposure
Year: 2015 PMID: 27275278 PMCID: PMC4877847 DOI: 10.3889/oamjms.2015.086
Source DB: PubMed Journal: Open Access Maced J Med Sci ISSN: 1857-9655
Demographics of the study subjects
| Variable | Parquet manufacturers (n = 37) | Office workers (n = 37) |
|---|---|---|
| Age (years) | 44.9 ± 7.8 | 45.2 ± 5.4 |
| BMI (kg/m2) | 25.1 ± 3.1 | 25.8 ± 3.8 |
| Duration of employment (actual workplace, years) | 17.4 ± 4.3 | 18.1 ± 3.9 |
| Duration of employment less than 15 years | 21 (56.8%) | 19 (51.3%) |
| Duration of employmentmore than 15 years | 16 (43.2%) | 18 (48.7%) |
| Family history of asthma/chronic bronchitis | 5 (13.5%) | 4 (10.8%) |
| Environmental ETS | 18 (48.6%) | 15 (40.5%) |
| Accompanying diseases | ||
| Arterial hypertension | 5 (13.5%) | 5 (13.5%) |
| Diabetes mellitus type 2 | 2 (5.4%) | 3 (8.1%) |
| Musculoskeletal disorders | 6 (16.2%) | 4 (10.8%) |
| Peptic ulcer | 3 (8.1%) | 4 (10.8%) |
Numerical data are expressed as mean value with standard deviation; frequencies as number and percentage of study subjects with certain variable. BMI: body mass index; kg: kilogram; m: meter; ETS: exposure to tobacco smoke.
Prevalence of respiratory symptoms in the last 12 months
| Respiratory symptoms in the last 12 months | Parquet manufacturers (n = 37) | Office workers (n = 37) | |
|---|---|---|---|
| Overall respiratory symptoms | 16 (43.2%) | 9 (24.3%) | 0.092 |
| Cough | 11 (29.7%) | 5 (13.5%) | 0.044 |
| Phlegm | 6 (16.2%) | 2 (5.4%) | 0.021 |
| Dyspnea | 4 (10.8%) | 3 (8.1%) | 0.119 |
| Wheezing | 3 (8.1%) | 2 (5.4%) | 0.143 |
| Chest tightness | 5 (13.5%) | 4 (10.8%) | 0.138 |
Data are expressed as number and percentage of study subjects with certain variable.
Tested by Chi-square test (or Fisher’s exact test where appropriate).
Figure 1Prevalence of overall respiratory symptoms in the last 12 months.
Figure 2Prevalence of particular respiratory symptoms in the last 12 months.
Figure 3Work-relatedness of the respiratory symptoms in the last 12 months.
Prevalence of respiratory symptoms in the last 12 months in the parquet manufacturers with duration of exposure at the actual workplace more and less than 15 years
| Respiratory symptoms in the last 12 months | Duration of exposure > 15 years | Duration of exposure < 15 years | |
|---|---|---|---|
| Overall respiratory symptoms | 12/16 (75.0%) | 4/16 (25.0%) | 0.037 |
| Cough | 8/11 (72.7%) | 3/11 (27.3%) | 0.040 |
| Phlegm | 5/6 (83.3%) | 1/6 (16.7%) | 0.014 |
| Dyspnea | 2/4 (50.0%) | 2/4 (50.0%) | 1.000 |
| Wheezing | 2/3 (66.6%) | 1/3 (33.3%) | 0.083 |
| Chest tightness | 2/5 (40.0%) | 3/5 (60.0%) | 0.108 |
Data are expressed as number and percentage of study subjects with certain variable.
Tested by Chi-square test (or Fisher’s exact test where appropriate).
Mean baseline values of spirometric parameters
| Spirometric parameter | Parquet manufacturers | Office workers | |
|---|---|---|---|
| (n = 37) | (n = 37) | ||
| FVC (%pred) | 92.3 ± 14.7 | 94.2 ± 11.4 | 0.088 |
| FEV1 (%pred) | 82.6 ± 10.2 | 86.8 ± 9.4 | 0.034 |
| FEV1/FVC | 0.75 ± 0.05 | 0.78 ± 0.03 | 0.037 |
| MEF25 (%pred) | 70.3 ± 8.9 | 76.9 ± 7.4 | 0.029 |
| MEF50 (%pred) | 64.6 ± 13.8 | 72.7 ± 10.5 | 0.011 |
| MEF75 (%pred) | 60.2 ± 16.7 | 69.7 ± 11.8 | 0 |
| MEF25-75 (%pred) | 65.9 ± 14.1 | 70.8 ± 12.9 | 0.006 |
Data are expressed as mean value with standard deviation. FVC: forced vital capacity; FEV1: forced expiratory volume in one second; MEF75, MEF50, MEF25, MEF25-75: maximal expiratory flow at 25, 50%, 75% and 25-75% of FVC, respectively; % pred: % of predicted value.
Compared by Independent-samples T-test.
Mean baseline values of spirometric parameters in the parquet manufacturers with duration of exposure at the actual workplace longer and shorter than 15 years
| Spirometric parameter | Duration of exposure | Duration of exposure | |
|---|---|---|---|
| > 15 years | < 15 years | ||
| FVC (%pred) | 90.4 ± 12.6 | 93.2 ± 10.9 | 0.038 |
| FEV1 (%pred) | 79.2 ± 9.8 | 84.3 ± 11.4 | 0.029 |
| FEV1/FVC | 0.74 ± 0.02 | 0.76 ± 0.04 | 0.022 |
| MEF25 (%pred) | 68.5 ± 11.7 | 72.6 ± 10.8 | 0.012 |
| MEF50 (%pred) | 61.3 ± 10.2 | 67.1 ± 11.9 | 0.002 |
| MEF75 (%pred) | 56.1 ± 13.4 | 64.2 ± 12.8 | 0 |
| MEF25-75 (%pred) | 62.7 ± 14.3 | 68.9 ± 12.1 | 0.003 |
Data are expressed as mean value with standard deviation. FVC: forced vital capacity; FEV1: forced expiratory volume in one second; MEF75, MEF50, MEF25, MEF25-75: maximal expiratory flow at 25, 50%, 75% and 25-75% of FVC, respectively; % pred: % of predicted value.
Compared by Independent-samples T-test.